MapLight Therapeutics is a clinical-stage biopharmaceutical company pioneering the development of innovative therapies for central nervous system disorders. We leverage a unique platform combining single-cell transcriptomics and optogenetics to identify novel drug targets and create effective treatments for debilitating brain conditions such as schizophrenia and Alzheimer's disease psychosis. Our approach allows us to precisely target neural circuits implicated in these disorders, leading to more effective and safer therapies with fewer side effects. We are a rapidly growing company with a strong emphasis on scientific rigor and collaborative innovation. Our tech stack includes tools like Google Tag Manager for analytics, a robust mobile-first website design, and secure infrastructure incorporating HSTS and DNSSEC. We foster a dynamic and supportive environment where cutting-edge science meets practical application. Our team values collaboration, creativity, and a commitment to making a significant impact in the field of neuroscience. We're backed by leading investors such as 5AM Ventures, Cowen Healthcare Investments, and Novo Holdings, and have recently completed a Series C funding round. We are currently expanding our team and seeking talented individuals passionate about transforming the treatment of brain disorders. Our focus is on bringing groundbreaking treatments to patients, making a real difference in their lives, and contributing to the advancement of neuroscience. We offer competitive salaries and benefits, opportunities for professional development, and a collaborative work environment where individuals can thrive. We are committed to providing all qualified applicants with consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by law.